MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-02-0022402
Neogenesis Biomedical Private Limited
Neogenesis Biomedical Private Limited - business services in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹1.57 Cr
▲ 82% YoY
Net profit · FY 2024
₹7.76 Lakh
Net margin 4.9%
EBITDA · FY 2024
₹10.54 Lakh
EBITDA margin 6.7%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Employees · EPFO
6
Provident fund records
Directors on board
2
As per MCA filings
About Neogenesis Biomedical Private Limited
Data last updated:
Neogenesis Biomedical Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 08 February 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2018PTC122179. Its GSTIN is 36AAFCN9298M1ZI (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Maya Muralidhar Naidu and Vaishnavi Naidu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 207 3rd Floor Uma Nagar Janapriya Pramila Enclaves, Hyderabad, Telangana, India – 500016.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.57 Cr, a growth of 82% compared to the previous year. For the same year it recorded a net profit of ₹7.76 Lakh (net margin 4.9%) and EBITDA of ₹10.54 Lakh (EBITDA margin 6.7%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 20% over five years.
The company has about 6 employees on its provident fund (EPFO) records.
Neogenesis Biomedical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0022402).
Company details
CIN U74999TG2018PTC122179
Registration Number 122179
Incorporation Date 08 February 2018
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0022402
Recognitions & Rankings of Neogenesis Biomedical
Contact details
Neogenesis Biomedical Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Social Media
- Registered AddressFlat No. 207 3rd Floor Uma Nagar Janapriya Pramila Enclaves, Hyderabad, Telangana, India – 500016
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
To see the full contact details of Neogenesis Biomedical Private Limited, buy the company report.
Comprehensive company report
Neogenesis Biomedical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Neogenesis Biomedical is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Neogenesis Biomedical Private Limited, buy the company report.
Financials of Neogenesis Biomedical Private Limited
FY 2025 filings availableNeogenesis Biomedical Private Limited reported revenue of ₹1.57 Cr (up 82% YoY) for FY 2024.
Revenue · FY 2024
₹1.57 Cr ▲ 82%
Net profit · FY 2024
₹7.76 Lakh margin 4.9%
EBITDA · FY 2024
₹10.54 Lakh margin 6.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 82%
3 years · compounded
▼ 12%
5 years · compounded
▲ 20%
EBITDA CAGR growth
1 year
▲ 228%
3 years · compounded
▲ 30%
5 years · compounded
▲ 43%
Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 82% growth in the latest year. EBITDA rose 228% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.54 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.76 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.7% | ||||
| Net Profit Margin | 4.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Neogenesis Biomedical Private Limited, buy the company report.
Board of directors of Neogenesis Biomedical Private Limited
Neogenesis Biomedical has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Maya Muralidhar Naidu | Director | 08 Feb 2018 | 8 Years 8 Months | Current |
| Vaishnavi Naidu Also directs: Neointegrity Ambulance Fabrication Private Limited | Director | 08 Feb 2018 | 8 Years 8 Months | Current |
Peer comparison
Neogenesis Biomedical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Betanet Consultancy Private Limited | ₹1.58 Cr (FY 2025) | 5.0% | Gandhinagar, Gujarat, India | |||
| Accurex Measurement Technologies Private Limited | ₹1.58 Cr (FY 2024) | 238.0% | Arsikere, Karnataka, India | |||
| Mekong Vacations Private Limited | ₹1.57 Cr (FY 2025) | 685.0% | Kolkata, West Bengal, India | |||
| Sanandsam India Private Limited | ₹1.57 Cr (FY 2025) | -65.0% | Gurgaon, Haryana, India | |||
| Nuix Technologies Private Limited | ₹1.57 Cr (FY 2025) | -2.0% | Gurgaon, Haryana, India | |||
| Neogenesis Biomedical Private Limitedthis company | ₹1.57 Cr (FY 2024) | ₹7.76 Lakh | 4.9% | 82.0% | 6 | Hyderabad, Telangana, India |
| Clariant Petro Private Limited | ₹1.57 Cr (FY 2025) | 142.0% | Kolkata, West Bengal, India | |||
| Vikas Extrusions Private Limited | ₹1.57 Cr (FY 2025) | 70.0% | Delhi, India | |||
| Taneja Crockery Private Limited | ₹1.57 Cr (FY 2019) | -18.0% | Delhi, India | |||
| Sarigo India Retails and Logistics Private Limited | ₹1.57 Cr (FY 2021) | 2489.0% | Guwahati, Assam, India | |||
| Cristova Biosciences Private Limited | ₹1.57 Cr (FY 2024) | 73.0% | Shamirpet, Telangana, India |
To see the full peer comparison of Neogenesis Biomedical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Neogenesis Biomedical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Neogenesis Biomedical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Neogenesis Biomedical Private Limited has a workforce of 6 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
Employee count
6
Active EPFO establishments
1
Employee growth
-33.33%
GST
Neogenesis Biomedical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCN9298M1ZI | Telangana | Active | 08 Feb 2018 |
To see the full GST registrations and return filing status of Neogenesis Biomedical Private Limited, buy the company report.
Recent activity
Neogenesis Biomedical Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Maya Muralidhar Naidu was appointed as Director on 08 Feb 2018.
AGM
Neogenesis Biomedical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Neogenesis Biomedical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Maya Muralidhar Naidu was appointed as Director.
Appointed
Vaishnavi Naidu was appointed as Director.
Incorporation
08 Feb 2018
Neogenesis Biomedical Private Limited was registered on 08 Feb 2018 with Roc Hyderabad & aged 8 years 8 months as per MCA records.
Frequently asked questions
Neogenesis Biomedical is an active private limited company based in Hyderabad, Telangana, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 08 February 2018 (8+ years old) and is registered under CIN U74999TG2018PTC122179.
Neogenesis Biomedical has 2 current directors:
- Maya Muralidhar Naidu - Director
- Vaishnavi Naidu - Director
The latest financial statements of Neogenesis Biomedical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Neogenesis Biomedical is 36AAFCN9298M1ZI, registered in Telangana.
The CIN (Corporate Identification Number) of Neogenesis Biomedical is U74999TG2018PTC122179. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neogenesis Biomedical was incorporated on 08 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Neogenesis Biomedical by revenue are Betanet Consultancy Private Limited, Accurex Measurement Technologies Private Limited, Mekong Vacations Private Limited, Sanandsam India Private Limited, Nuix Technologies Private Limited and 5 more, all in the same principal business activity (retail trading).
Maya Muralidhar Naidu was appointed as Director on 08 Feb 2018. Vaishnavi Naidu was appointed as Director on 08 Feb 2018.
Yes, Neogenesis Biomedical is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0022402).
The registered office of Neogenesis Biomedical is at Flat No. 207 3rd Floor Uma Nagar Janapriya Pramila Enclaves, Hyderabad, Telangana, India – 500016.
Neogenesis Biomedical operates in the business services industry, in the miscellaneous business activities segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages